These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1512690)

  • 1. Further studies of salivary inhibition of HIV-1 infectivity.
    Yeh CK; Handelman B; Fox PC; Baum BJ
    J Acquir Immune Defic Syndr (1988); 1992; 5(9):898-903. PubMed ID: 1512690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro inhibition of HIV-1 infectivity by human salivas.
    Archibald DW; Cole GA
    AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1425-32. PubMed ID: 2078420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HIV infectivity by human saliva.
    Malamud D; Nagashunmugam T; Davis C; Kennedy S; Abrams WR; Kream R; Friedman HM
    Oral Dis; 1997 May; 3 Suppl 1():S58-63. PubMed ID: 9456659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HIV-1 IIIB and clinical isolates by human parotid, submandibular, sublingual and palatine saliva.
    Bolscher JG; Nazmi K; Ran LJ; van Engelenburg FA; Schuitemaker H; Veerman EC; Nieuw Amerongen AV
    Eur J Oral Sci; 2002 Apr; 110(2):149-56. PubMed ID: 12013559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-HIV-1 activity associated with saliva.
    Shine N; Konopka K; Düzgüneş N
    J Dent Res; 1997 Feb; 76(2):634-40. PubMed ID: 9062556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.
    McNeely TB; Dealy M; Dripps DJ; Orenstein JM; Eisenberg SP; Wahl SM
    J Clin Invest; 1995 Jul; 96(1):456-64. PubMed ID: 7615818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous salivary inhibitors of human immunodeficiency virus.
    Shugars DC; Alexander AL; Fu K; Freel SA
    Arch Oral Biol; 1999 Jun; 44(6):445-53. PubMed ID: 10401522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids.
    Kazmi SH; Naglik JR; Sweet SP; Evans RW; O'Shea S; Banatvala JE; Challacombe SJ
    Clin Vaccine Immunol; 2006 Oct; 13(10):1111-8. PubMed ID: 16928883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-infectivity activity of human salivary secretions toward human immunodeficiency virus.
    Robinovitch MR; Iversen JM; Resnick L
    Crit Rev Oral Biol Med; 1993; 4(3-4):455-9. PubMed ID: 8397002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saliva and salivary gland alterations in HIV infection: a review.
    Matee MI; Simon E
    Afr Dent J; 1995; 9():25-9. PubMed ID: 9590897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation of secretory antibodies in parotid saliva to human immunodeficiency virus type 1 with HIV-1 disease stage.
    Sun D; Archibald DW; Furth PA
    AIDS Res Hum Retroviruses; 1990 Jul; 6(7):933-41. PubMed ID: 2117957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HIV-1 infection in vitro by murine monoclonal anti-p24 antibodies.
    Franke L; Grunow R; Meissner K; Porstmann T; von Baehr R
    J Med Virol; 1992 Jun; 37(2):137-42. PubMed ID: 1629712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human submandibular saliva specifically inhibits HIV type 1.
    Nagashunmugam T; Friedman HM; Davis C; Kennedy S; Goldstein LT; Malamud D
    AIDS Res Hum Retroviruses; 1997 Mar; 13(5):371-6. PubMed ID: 9075477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human submandibular saliva inhibits human immunodeficiency virus type 1 infection by displacing envelope glycoprotein gp120 from the virus.
    Nagashunmugam T; Malamud D; Davis C; Abrams WR; Friedman HM
    J Infect Dis; 1998 Dec; 178(6):1635-41. PubMed ID: 9815215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of HIV-1 and human salivary mucins.
    Bergey EJ; Cho MI; Blumberg BM; Hammarskjöld ML; Rekosh D; Epstein LG; Levine MJ
    J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):995-1002. PubMed ID: 8083829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral activity and protection of cells against human immunodeficiency virus type-1 using an antisense oligodeoxyribonucleotide phosphorothioate complementary to the 5'-LTR region of the viral genome.
    Anazodo MI; Salomon H; Friesen AD; Wainberg MA; Wright JA
    Gene; 1995 Dec; 166(2):227-32. PubMed ID: 8543166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory function of secretory leukocyte proteinase inhibitor (SLPI) in human saliva is HIV-1 specific and varies with virus tropism.
    Skott P; Lucht E; Ehnlund M; Björling E
    Oral Dis; 2002 May; 8(3):160-7. PubMed ID: 12108760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggregation of human immunodeficiency virus type 1 by human salivary secretions.
    Bergey EJ; Cho MI; Hammarskjöld ML; Rekosh D; Levine MJ; Blumberg BM; Epstein LG
    Crit Rev Oral Biol Med; 1993; 4(3-4):467-74. PubMed ID: 8373999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of HIV-Gag p24-specific antibodies in sera and saliva of HIV-1-infected adults and in sera of infants born to HIV-1-infected mothers.
    Yasuda S; Iwasaki M; Oka S; Naganawa S; Nakasone T; Honda M; Sata T; Kojima A; Matsuda S; Takemori T; Tsunetsugu-Yokota Y
    Microbiol Immunol; 1998; 42(4):305-11. PubMed ID: 9623918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and salivary IgG subclasses in HIV type 1 infection: evidence of both transudation and local synthesis of IgG in parotid saliva.
    Wu X; Jackson S
    AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1423-31. PubMed ID: 11018862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.